ADEA State Update

FDA Claims Benzocaine in Teething Pain Products Pose a “Serious Risk” to Young Children

(HHS, Dental Health) Permanent link   All Posts

The Food & Drug Administration (FDA) sent letters to manufacturers of over-the-counter (OTC) teething products and also issued a warning to consumers to stop using products that contain benzocaine on infants and small children. Marketed to temporarily relieve a child’s teething pain, the agency said these OTC products pose a “serious risk.” The FDA is taking steps to raise awareness of the risks associated with the use of these products in young children and is threatening regulatory action to remove these products from stores if companies fail to comply. The FDA action also impacts prescription anesthetics, which will need to update their product box warnings.

Duggan Dental